Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Laura R  – Israel, 2020-03-22 09:58 (985 d 15:08 ago) – Posting: # 21294
Views: 3,125

Hi, was wondering how P1 CROs are dealing with the COVID19 crisis, and if there is any chance to keep studies moving (in small cohorts, no overnight stays, etc).
Should HV studies considered an essential activity per the new FDA/EMA guidances, is voluteering in a Phase 1 study considered a valid reason to be outside? Laura

Complete thread:

UA Flag
 Admin contact
22,426 posts in 4,694 threads, 1,600 registered users;
14 visitors (0 registered, 14 guests [including 4 identified bots]).
Forum time: 01:06 CET (Europe/Vienna)

The art of medicine consists in amusing the patient
while nature cures the disease.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz